Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
BPMC Blueprint Medicines
- 96.570
- +6.150+6.80%
Close Feb 28 16:00 ET
- 96.570
- 0.0000.00%
Post 20:01 ET
6.17BMarket Cap-90.25P/E (TTM)
96.720High90.140Low1.03MVolume90.490Open90.420Pre Close98.27MTurnover1.63%Turnover RatioLossP/E (Static)63.91MShares121.90052wk High20.66P/B6.11BFloat Cap80.67552wk Low--Dividend TTM63.25MShs Float125.610Historical High--Div YieldTTM7.28%Amplitude13.040Historical Low95.241Avg Price1Lot Size
About Blueprint Medicines Company
Blueprint Medicines Corp. is a precision therapy company, which engages in the provision of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
Company Profile
SymbolBPMC
Company NameBlueprint Medicines
Listing DateApr 30, 2015
Issue Price18.00
Founded2008
CEOMs. Kathryn Haviland
MarketNASDAQ
Employees649
Fiscal Year Ends12-31
Address45 Sidney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-374-7580
Company Executives
- Name
- Position
- Salary
- Kathryn Haviland
- Director, President and Chief Executive Officer
- 6.43M
- Dr. Percy H. Carter, M.B.A.,PhD
- Chief Scientific Officer
- 2.30M
- Tracey L. McCain, Esq.
- Chief Legal and Compliance Officer
- --
- Christina Rossi, M.B.A.
- Chief Operating Officer
- 2.81M
- Debra Durso-Bumpus
- Chief People Officer
- --
- Dr. Becker Hewes, M.D.
- Chief Medical Officer
- --
- Michael Landsittel, M.B.A.
- Chief Financial Officer
- 2.19M
- Dr. Philina Lee, PhD
- Chief Commercial Officer
- --
- Dr. Christopher K. Murray, PhD
- Chief Technical Operations and Quality Officer
- --
- Ariel Hurley
- Senior Vice President, Finance and Principal Accounting Officer
- --
- Jeffrey W. Albers, J.D.
- Chairman of the Board
- 526.08K
- Dr. Fouad Namouni, M.D.
- President, Research and Development
- 2.80M
- Alexis A. Borisy, A.M.
- Director
- 397.33K
- Dr. Mark Alan Goldberg, M.D.
- Independent Director
- 419.33K
- Dr. Nicholas Lydon, F.R.S.,PhD
- Independent Director
- 417.33K
- Daniella Beckman
- Independent Director
- 422.33K
- Lonnel Coats
- Independent Director
- 419.33K
- Habib Joseph Dable
- Independent Director
- 412.33K
- Dr. Lynn Seely,M.D.
- Lead Independent Director
- 452.33K
- Dr. John Tsai, M.D.
- Independent Director
- 769.80K
